Evaluation of the Reasons and Consequences of Bleeding in Late Teens and Early Adulthood Patients With Severe Hemophilia A

Conditions

• Hematologic Disease
• Blood Coagulation Disorders

Interventions

• BEHAVIORAL: Recombinant Factor VIII (Kogenate, BAY 14-2222)
• BEHAVIORAL: Recombinant Factor VIII (Kogenate, BAY 14-2222)
• BEHAVIORAL: Recombinant Factor VIII (Kogenate, BAY 14-2222)

Sponsor

Bayer